SLURP1 mutation-impaired T-cell activation in a family with mal de Meleda

British Journal of Dermatology

Volumn 164, Issue 1, 2011, Pages 47-53

  Tjiu, J W ^a   Lin, P J ^a   Wu, W H ^a   Cheng, Y P ^a   Chiu, H C ^a   Thong, H Y ^a   Chiang, B L ^b   Yang, W S ^b   Jee, S H ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ARGININE; CD3 ANTIBODY; FLUORODEOXYGLUCOSE F 18; GLYCINE; GUANOSINE; LYMPHOCYTE ANTIGEN 6 UROKINASE TYPE PLASMINOGEN ACTIVATOR RECEPTOR RELATED PROTEIN 1; MONOCLONAL ANTIBODY CD28; NUCLEOTIDE; RECOMBINANT HUMAN LYMPHOCYTE ANTIGEN 6 UROKINASE TYPE PLASMINOGEN ACTIVATOR RECEPTOR RELATED PROTEIN 1; RECOMBINANT PROTEIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ACRAL LENTIGINOUS MELANOMA; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CELL ISOLATION; CELL STIMULATION; DRUG UPTAKE; ETHNIC GROUP; FAMILY; FINGER; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GIANT VERRUCA; HETEROZYGOSITY; HOMOZYGOSITY; HOMOZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; MAL DE MELEDA; MALE; MELANOMA; PALMOPLANTAR KERATODERMA; PERIPHERAL BLOOD MONONUCLEAR CELL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SKIN BIOPSY; T LYMPHOCYTE ACTIVATION; TAIWANESE; VIRUS INFECTION; WILD TYPE;

EID: 78650504159     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.10059.x     Document Type: Article

References (36)

1. Lucker GP, van de Kerkhof PC, Steijlen PM,. The hereditary palmoplantar keratoses: an updated review and classification. Br J Dermatol 1994; 131: 1-14.
2. Bergman R, Bitterman-Deutsch O, Fartasch M, et al. Mal de Meleda keratoderma with pseudoainhum. Br J Dermatol 1993; 128: 207-12. (Pubitemid 23054341)
3. Jee SH, Lee YY, Wu YC, et al. Report of a family with mal de Meleda in Taiwan: a clinical, histopathological and immunological study. Dermatologica 1985; 171: 30-7.
4. Fischer J, Bouadjar B, Heilig R, et al. Mutations in the gene encoding SLURP-1 in Mal de Meleda. Hum Mol Genet 2001; 10: 875-80. (Pubitemid 32331598)
5. Ward KM, Yerebakan O, Yilmaz E, et al. Identification of recurrent mutations in the ARS (component B) gene encoding SLURP-1 in two families with mal de Meleda. J Invest Dermatol 2003; 120: 96-8. (Pubitemid 36120976)
6. Mastrangeli R, Donini S, Kelton CA, et al. ARS component B: structural characterization, tissue expression and regulation of the gene and protein (SLURP-1) associated with mal de Meleda. Eur J Dermatol 2003; 13: 560-70. (Pubitemid 38030798)
7. Favre B, Plantard L, Aeschbach L, et al. SLURP1 is a late marker of epidermal differentiation and is absent in mal de Meleda. J Invest Dermatol 2007; 127: 301-8. (Pubitemid 46106906)
8. Faghih R, Gfesser GA, Gopalakrishnan M,. Advances in the discovery of novel positive allosteric modulators of the alpha7 nicotinic acetylcholine receptor. Recent Pat CNS Drug Discov 2007; 2: 99-106. (Pubitemid 46957322)
9. Chimienti F, Hogg RC, Plantard L, et al. Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of mal de Meleda. Hum Mol Genet 2003; 12: 3017-24. (Pubitemid 37442029)
10. Grando SA,. Basic and clinical aspects of non-neuronal acetylcholine: biological and clinical significance of non-canonical ligands of epithelial nicotinic acetylcholine receptors. J Pharmacol Sci 2008; 106: 174-9. (Pubitemid 351366334)
11. Arredondo J, Chernyavsky AI, Webber RJ, et al. Biological effects of SLURP-1 on human keratinocytes. J Invest Dermatol 2005; 125: 1236-41.
12. Moriwaki Y, Yoshikawa K, Fukuda H, et al. Immune system expression of SLURP-1 and SLURP-2, two endogenous nicotinic acetylcholine receptor ligands. Life Sci 2007; 80: 2365-8. (Pubitemid 46818253)
13. Kawashima K, Yoshikawa K, Fujii YX, et al. Expression and function of genes encoding cholinergic components in murine immune cells. Life Sci 2007; 80: 2314-19. (Pubitemid 46818285)
14. Moriwaki Y, Watanabe Y, Shinagawa T, et al. Primary sensory neuronal expression of SLURP-1, an endogenous nicotinic acetylcholine receptor ligand. Neurosci Res 2009; 64: 403-12.
15. Pettersson A, Nordlander S, Nylund G, et al. Expression of the endogenous, nicotinic acetylcholine receptor ligand, SLURP-1, in human colon cancer. Auton Autacoid Pharmacol 2008; 28: 109-16.
16. 2+ response. J Immunol 2007; 179: 2889-98.
17. De Rosa MJ, Dionisio L, Agriello E, et al. Alpha 7 nicotinic acetylcholine receptor modulates lymphocyte activation. Life Sci 2009; 85: 444-9.
18. Eckl KM, Stevens HP, Lestringant GG, et al. Mal de Meleda (MDM) caused by mutations in the gene for SLURP-1 in patients from Germany, Turkey, Palestine, and the United Arab Emirates. Hum Genet 2003; 112: 50-6.
19. Chao SC, Lai FJ, Yang MH, Lee JY,. Mal de Meleda in a Taiwanese. J Formos Med Assoc 2005; 104: 276-8.
20. Wickner S, Maurizi MR, Gottesman S,. Posttranslational quality control: folding, refolding, and degrading proteins. Science 1999; 286: 1888-93. (Pubitemid 129515889)
21. Meusser B, Hirsch C, Jarosch E, et al. ERAD: the long road to destruction. Nat Cell Biol 2005; 7: 766-72. (Pubitemid 41079045)
22. Kawashima K, Fujii T,. The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci 2003; 74: 675-96. (Pubitemid 37494897)
23. Fujii T, Takada-Takatori Y, Kawashima K,. Basic and clinical aspects of non-neuronal acetylcholine: expression of an independent, non-neuronal cholinergic system in lymphocytes and its clinical significance in immunotherapy. J Pharmacol Sci 2008; 106: 186-92. (Pubitemid 351366336)
24. Wongsriraksa A, Parsons ME, Whelan CJ,. Characterisation of nicotine receptors on human peripheral blood mononuclear cells (PBMC). Inflamm Res 2009; 58: 38-44.
25. Fujii T, Yamada S, Watanabe Y, et al. Induction of choline acetyltransferase mRNA in human mononuclear leukocytes stimulated by phytohemagglutinin, a T-cell activator. J Neuroimmunol 1998; 82: 101-7. (Pubitemid 28129342)
26. Grando SA, Pittelkow MR, Schallreuter KU,. Adrenergic and cholinergic control in the biology of epidermis: physiological and clinical significance. J Invest Dermatol 2006; 126: 1948-65. (Pubitemid 44244840)
27. Nakajima K, Nakano H, Takiyoshi N, et al. Papillon-Lefåvre syndrome and malignant melanoma. A high incidence of melanoma development in Japanese palmoplantar keratoderma patients. Dermatology 2008; 217: 58-62. (Pubitemid 351896572)
28. Sartore L, Bordignon M, Bassetto F, et al. Melanoma in skin affected with keratoderma palmoplantaris hereditaria (mal de Meleda): treatment with excision and grafting. J Am Acad Dermatol 2009; 61: 161-3.
29. Mozzillo N, Nunziata CA, Caraco C, et al. Malignant melanoma developing in an area of hereditary palmoplantar keratoderma (mal de Meleda). J Surg Oncol 2003; 84: 229-33. (Pubitemid 37484788)
30. Arredondo J, Chernyavsky AI, Grando SA,. Overexpression of SLURP-1 and -2 alleviates the tumorigenic action of tobacco-derived nitrosamine on immortalized oral epithelial cells. Biochem Pharmacol 2007; 74: 1315-19. (Pubitemid 47417920)
31. Ladanyi A, Somlai B, Gilde K, et al. T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma. Clin Cancer Res 2004; 10: 521-30. (Pubitemid 38173990)
32. Pham CT, Ivanovich JL, Raptis SZ, et al. Papillon-Lefåvre syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin C/dipeptidyl peptidase I deficiency in humans. J Immunol 2004; 173: 7277-81.
33. Ullbro C, El-Samadi S, Boumah C, et al. Phenotypic variation and allelic heterogeneity in young patients with Papillon-Lefåvre syndrome. Acta Derm Venereol (Stockh) 2006; 86: 3-7. (Pubitemid 46939779)
34. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405: 458-62. (Pubitemid 30367422)
35. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-8. (Pubitemid 36157937)
36. Horiguchi K, Horiguchi S, Yamashita N, et al. Expression of SLURP-1, an endogenous alpha7 nicotinic acetylcholine receptor allosteric ligand, in murine bronchial epithelial cells. J Neurosci Res 2009; 87: 2740-7.